Status:
COMPLETED
Glycemic Evaluation of Novel Staple Foods
Lead Sponsor:
National University of Singapore
Conditions:
Diabete Type 2
Diabetes Mellitus
Eligibility:
All Genders
21-70 years
Phase:
NA
Brief Summary
In this study, the combined effects of functional foods (i.e. Anthocyanin fortified bread, Microfluidic co-flow noodles, 5ibrePlus™-fortified white rice) is investigated in an ad-libitum diet and thei...
Detailed Description
Research has confirmed that a food's glycemic effect cannot be accurately predicted from the type and amount of carbohydrates it contains, as the rate at which the carbohydrates is digested and releas...
Eligibility Criteria
Inclusion
- Chinese ethnicity
- English-speaking
- Age between 21 - 70 years old inclusive.
- Confirmed Type 2 Diabetes with HbA1c level of less than 10%
- Not on prandial insulin therapy
- Subjects with stable medical problems not limited to hypertension and hyperlipidemia
Exclusion
- Current smoker or use of tobacco products within the 3 months
- Vegetarian or other dietary restrictions that would not allow the subject to consume the test meal.
- Persons with electronic medical implants (e.g. pacemaker).
- Persons with known or ongoing psychiatric disorders or drug abuse within 3 years.
- Women who are pregnant or lactating.
- Persons with an average weekly alcohol intake that exceeds 21 units per week (males) and 14 units per week (females). 1 unit is equivalent to:
- 12 oz or 360 mL of beer;
- 5 oz or 150 mL of wine;
- 5 oz or 45 mL of distilled spirits.
- Persons with active infection(s) requiring systemic, antiviral or antimicrobial therapy that will not be completed prior to the first study visit
- Persons who have undergone treatment with any investigational drug or biological agent within one (1) month of screening or plans to enroll in another study involving investigational drugs/biological agents during the duration of this study.
- Persons with significant change in weight (+/- 5%) during the past month.
- Persons with a known allergy to rice bran, dietary fiber, alginate and other study components (anthocyanins, soy protein).
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 19 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05399134
Start Date
January 1 2021
End Date
May 19 2023
Last Update
November 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University of Singapore
Singapore, Singapore, Singapore, 118177